Archive - November 2018
EU gives Bayer’s Jivi the green light
Novartis to move UK headquarters to London
NHS cracks down on low-priority prescriptions
FDA Approves Xospata (gilteritinib) for Acute Myeloid Leukemia (AML) with a FLT3 Mutation
FDA Approves Truxima (rituximab-abbs), a Biosimilar to Rituxan for Non-Hodgkin’s Lymphoma
Avenir acquires Cherry, EY wins new account and GK unites businesses
Novo Nordisk launches type II diabetes awareness campaign
Medical devices probe uncovers need for “drastic regulatory changes”